Safety and Pharmacokinetics of Once-Daily Regimens of Soft-Gel Capsule Saquinavir plus Minidose Ritonavir in Human Immunodeficiency Virus-Negative Adults

Human immunodeficiency virus type 1 (HIV-1) protease inhibitors have dramatically improved treatment options for HIV infection, but frequent dosing may impact adherence to highly active antiretroviral treatment regimens (HAART). Previous studies demonstrated that combined therapy with ritonavir and...

Celý popis

Podrobná bibliografie

Vydáno v:	Antimicrob Agents Chemother
Hlavní autoři:	Kilby, J. Michael, Sfakianos, Greg, Gizzi, Nick, Siemon-Hryczyk, Peggy, Ehrensing, Eric, Oo, Charles, Buss, Neil, Saag, Michael S.
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	American Society for Microbiology (ASM) 2000
Témata:	Pharmacology
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90133/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10991842/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.10.2672-2678.2000
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!